Skip to main content
Premium Trial:

Request an Annual Quote

GE's Reported Plans to Buy Abbott Dx Topped Most-Read GenomeWeb News Stories Last Week

NEW YORK (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Jan. 19.
 
1. GE Healthcare Said to Be Close to Acquiring Abbott Diagnostics In Further Dx Reorganization (from Jan. 18)
 
2. Abbott's Molecular Dx Unit Untouched as GE Plans to Buy In Vitro, POC Segments for $8B (from Jan. 19)
  
3. Cepheid and BioMerieux to Develop, Market Sepsis Assays (from Jan. 17)
 
4. ABI, BG Medicine Team on Industrial-Scale Biomarker Research (from Jan. 16)
 
5. Pfizer Buys Dx Rights to Genizon Research Programs, Takes Equity Stake in Firm (from Jan. 16) 
The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.